224 related articles for article (PubMed ID: 17855626)
1. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
2. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
3. Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.
Yin B; Lee BS; Yang-Iott KS; Sleckman BP; Bassing CH
J Immunol; 2012 Aug; 189(3):1372-9. PubMed ID: 22730535
[TBL] [Abstract][Full Text] [Related]
4. The RAG2 C terminus suppresses genomic instability and lymphomagenesis.
Deriano L; Chaumeil J; Coussens M; Multani A; Chou Y; Alekseyenko AV; Chang S; Skok JA; Roth DB
Nature; 2011 Mar; 471(7336):119-23. PubMed ID: 21368836
[TBL] [Abstract][Full Text] [Related]
5. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
[TBL] [Abstract][Full Text] [Related]
6. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
7. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht M; Jacks T
Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
[TBL] [Abstract][Full Text] [Related]
8. RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ
Mol Cell Biol; 2002 May; 22(9):3174-7. PubMed ID: 11940674
[TBL] [Abstract][Full Text] [Related]
9. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.
DeMicco A; Yang-Iott K; Bassing CH
Cell Cycle; 2013 Oct; 12(20):3307-16. PubMed ID: 24036547
[TBL] [Abstract][Full Text] [Related]
10. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.
Zha S; Bassing CH; Sanda T; Brush JW; Patel H; Goff PH; Murphy MM; Tepsuporn S; Gatti RA; Look AT; Alt FW
J Exp Med; 2010 Jul; 207(7):1369-80. PubMed ID: 20566716
[TBL] [Abstract][Full Text] [Related]
11. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
[TBL] [Abstract][Full Text] [Related]
12. No requirement for V(D)J recombination in p53-deficient thymic lymphoma.
Liao MJ; Zhang XX; Hill R; Gao J; Qumsiyeh MB; Nichols W; Van Dyke T
Mol Cell Biol; 1998 Jun; 18(6):3495-501. PubMed ID: 9584189
[TBL] [Abstract][Full Text] [Related]
13. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
[TBL] [Abstract][Full Text] [Related]
14. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
15. Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.
Yin B; Savic V; Juntilla MM; Bredemeyer AL; Yang-Iott KS; Helmink BA; Koretzky GA; Sleckman BP; Bassing CH
J Exp Med; 2009 Nov; 206(12):2625-39. PubMed ID: 19887394
[TBL] [Abstract][Full Text] [Related]
16. ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo.
Dujka ME; Puebla-Osorio N; Tavana O; Sang M; Zhu C
Oncogene; 2010 Feb; 29(7):957-65. PubMed ID: 19915617
[TBL] [Abstract][Full Text] [Related]
17. Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development.
Liu X; Jiang W; Dubois RL; Yamamoto K; Wolner Z; Zha S
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3903-8. PubMed ID: 22355127
[TBL] [Abstract][Full Text] [Related]
18. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
[TBL] [Abstract][Full Text] [Related]
19. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
[TBL] [Abstract][Full Text] [Related]
20. Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
Petiniot LK; Weaver Z; Barlow C; Shen R; Eckhaus M; Steinberg SM; Ried T; Wynshaw-Boris A; Hodes RJ
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6664-9. PubMed ID: 10841564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
